Statement Of Cash Flows [Abstract]

Neurones S.A. - Filing #5981664

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
10 190 EUR
4 908 EUR
Cash flows from (used in) operations before changes in working capital
100 735 EUR
96 035 EUR
Increase (decrease) in working capital
8 459 EUR
1 393 EUR
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
- EUR
819,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
1 791 EUR
2 067 EUR
Proceeds from sales or maturity of financial instruments, classified as investing activities
324,000 EUR
846,000 EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
29 126 EUR
26 647 EUR
Dividends paid to non-controlling interests, classified as financing activities
8 183 EUR
1 791 EUR
Proceeds from contributions of non-controlling interests
1 397 EUR
1 084 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.